Gate Bioscience Signs $856 Million Collaboration and License Agreement with Eli Lilly

Leila Ahmed North America Legal Chronicle
Tagged:

WilmerHale has advised Gate Bioscience on the deal.Gate Bioscience, a biotechnology company focused on developing molecular gates—a new class of small molecule drugs aimed at eliminating…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Leila Ahmed

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here